Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia.
about
Building the power house: recent advances in mitochondrial studies through proteomics and systems biology.Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia.Identification of molecular markers for pre-engraftment immune reactions after cord blood transplantation by SELDI-TOF MS.Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.Apolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection.Proteomic analysis of haptoglobin and amyloid A protein levels in patients with vivax malaria.Detection of serum tumor markers in multiple myeloma using the CLINPROT system.Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia.Construction of protein profile classification model and screening of proteomic signature of acute leukemiaNon-invasive detection of drug toxicity in rats by solid-phase extraction and MALDI-TOF analysis of urine samples.Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature.Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling.Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation.Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia.
P2860
Q33252676-389F7792-07CC-442D-87DE-28BE1D3F5E38Q33418760-201307A0-7D26-435B-A1CB-481D9DB8EA6CQ33540684-3E36CFC2-26AE-4CDE-B01E-6B82663862EFQ33745000-50C2B685-5219-4E15-A054-2E817804D3BEQ33951763-F54FC44F-DD0E-4510-AF69-B2E0D8F2D6EFQ34156170-5B2501D4-8227-42A6-AD77-F50BE37B7967Q34249148-A10E5011-DEA6-42A8-87A3-159780BA67C8Q34333169-B54EAC29-4BAC-4FBA-90A4-23A547F1FA5FQ34371208-5F840FCC-110D-4E74-B381-D1BD6C040814Q34546734-FDD219BB-E367-4223-AC57-032EC9743175Q35070288-59259B72-198C-42AD-ACB6-7E0C21348420Q37114841-EF65FA21-E49D-49FD-8637-DCED88E659D4Q37182247-25EA7CEE-C08A-4339-A0BE-79E37CECFD03Q41583667-C0E93D92-6339-4391-99A6-8E68738895F6
P2860
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia.
@ast
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia.
@en
type
label
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia.
@ast
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia.
@en
prefLabel
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia.
@ast
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia.
@en
P2093
P50
P356
P1433
P1476
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia.
@en
P2093
Charlotte Clarke
Christine Aguilar
Deborah Thomas
Elihu Estey
Francis J Giles
Iman Jilani
Steven J Potts
P304
P356
10.1002/CNCR.21770
P407
P577
2006-04-01T00:00:00Z